News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Daily News Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force Michael O'Riordan October 11, 2017
News Daily News Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute Michael O'Riordan October 10, 2017
News Daily News Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs Michael O'Riordan October 03, 2017
News Daily News New Performance and Quality Metrics for STEMI and NSTEMI Care Michael O'Riordan September 21, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Daily News TAVR in the US: Regional Variations in Numbers, Outcomes Michael O'Riordan August 22, 2017
News Daily News FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts Michael O'Riordan August 17, 2017
News Daily News FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints Michael O'Riordan August 16, 2017
News Daily News Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests Michael O'Riordan August 14, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
News Daily News Boston Scientific Scraps Biodegradable Scaffold Program Michael O'Riordan August 01, 2017
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Daily News FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement Michael O'Riordan June 06, 2017